Both TRT and peptide therapy influence hormone-related systems, which is why combining them should always involve: Comprehensive lab testing Personalized dosing Ongoing monitoring Clear treatment goals When managed appropriately, combining TRT and peptides is typically about optimization and balance, not excess
You can support your endocrine system and restore optimal cortisol levels with a hormone detox, making lifestyle modifications, or taking supplements for hormone balancing
Timing Optional Monitoring guidance is label-informed for semaglutide and trial-informed/pathway-based for cagrilintide
While GHK-Cu is generally well-tolerated in topical research, certain contraindications or precautions should be considered, especially for systemic research or in specific populations: Systemic Research: For systemic applications, GHK-Cu is generally not recommended for subjects who are pregnant, breastfeeding, have active cancer, or suffer from Wilsons disease (a condition involving copper accumulation)
Related Articles We are here to help
